The abstract is read at the publisher; the summary is JClub's.
After menopause, women’s hypertension risk increases and accelerates beyond that of age-matched men, and women also show lower hypertension control rates than men.
- Why it matters: Sex differences in immune-mediated hypertension are linked to worse outcomes and different treatment responses, yet sex-specific clinical guidance and hormonal-status consideration remain limited.
- What they did: This review synthesizes recent advances on sex differences in immune-mediated hypertension, emphasizing gaps in immune mechanisms across males and females and noting that preclinical models are mainly in male animals.
- The result: The work identifies key research gaps in how immune pathways drive hypertension as menopause progresses, supporting more hormone-aware, sex-specific approaches to understanding and managing disease.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.